EMA Panel Backs Cannabis Drug for Severe Epilepsy

CHMP gives thumbs up to GW Pharma’s cannabidiol oral solution (Epidyolex) as an adjunctive treatment of Lennox-Gastaut syndrome and Dravet syndrome.
International Approvals

Source link

Related posts

Early prophylactic treatment reduces development of chronic post traumatic headache after concussion


neurological; +111 new citations


Asymptomatic systemic air embolism after CT-guided percutaneous transthoracic needle biopsy.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy